DHI

DR Horton
D

DHI

Arincen52/100B

DR Horton stock buybacks 1992–2026

DR Horton spent 1.31B USD buying back its shares in Q4 FY2026, the three months to 30 September 2026, up 86.4% on the same quarter a year before. DR Horton spent 3.52B USD buying back its shares over the last twelve months, down 17.7% on the twelve months before. In fiscal year 2026 it spent 3.52B USD, down 17.7% on the year before.

Last updated 6 Nov 2026 · Next report 19 Jan 2027

Stock buybacks

Growth

Fiscal yearPeriod endingStock buybacksGrowthDividends paidFree cash flow
TTM30 Sept 20263.52B-17.70%513.30M3.35B
FY202630 Sept 20263.52B-17.70%513.30M3.35B
FY202530 Sept 20254.28B+139.53%494.80M3.28B
FY202430 Sept 20241.79B+44.78%395.20M2.02B
FY202330 Sept 20231.23B+3.44%341.20M4.16B
FY202230 Sept 20221.19B+28.76%316.50M413.60M
FY202130 Sept 2021926.90M+132.54%289.30M267.00M
FY202030 Sept 2020398.60M-20.20%256.00M1.13B
FY201930 Sept 2019499.50M+262.48%223.40M668.00M
FY201830 Sept 2018137.80M+109.74%188.40M477.10M
FY201730 Sept 201765.70M+1,013.56%149.60M277.80M
FY201630 Sept 20165.90M—118.70M531.90M
FY201530 Sept 20150.00—91.60M644.30M
FY201430 Sept 20140.00—48.60M-761.60M
FY201330 Sept 20130.00—60.20M-1.29B
FY201230 Sept 20120.00-100.00%47.80M-322.30M
FY201130 Sept 201138.60M—47.80M-1.40M
FY201030 Sept 20100.00—47.70M690.20M
FY200930 Sept 20090.00—47.50M1.14B
FY200830 Sept 20080.00—142.00M1.87B
FY200730 Sept 20070.00-100.00%188.40M1.32B
FY200630 Sept 200636.80M—137.60M-1.27B
FY200530 Sept 20050.00—96.50M-688.90M
FY200430 Sept 20040.00-100.00%66.90M-477.70M
FY200330 Sept 200358.86M—40.10M374.65M
FY200230 Sept 20020.00—26.11M-130.42M
FY200130 Sept 20010.00-100.00%13.73M-88.65M
FY200030 Sept 200014.54M-35.08%9.29M-123.34M
FY199930 Sept 199922.40M—7.10M-188.20M
FY199830 Sept 19980.00-100.00%4.70M-136.90M
FY199730 Sept 19972.60M—2.10M-88.40M
FY199630 Sept 19960.00—1.40M-26.60M
FY199530 Sept 19950.00—0.00-34.70M
FY199430 Sept 19940.00—0.00-46.60M
FY199330 Sept 19930.00—0.00-20.30M
FY199230 Sept 19920.00—12.20M9.40M

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

The money spent buying back the company's own shares in each period, from the cash flow statement.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Cash flow

Common questions about DR Horton's buybacks

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.